Neoadjuvant immunotherapy plus chemotherapy and adjuvant targeted therapy in ALK -positive non-small-cell lung cancer.
Immunotherapy（2023）
关键词
adjuvant target therapy, ALK, checkpoint inhibitors, clinical immunology, crizotinib, neoadjuvant therapy, NSCLC, pembrolizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要